MarketPulse

exoskeleton

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Lifeward Shareholders Back Oramed Partnership to Diversify Into Biotech

Lifeward gains shareholder approval for strategic Oramed deal, securing up to $47M capital while expanding into oral delivery technology.
LFWDORMPstrategic partnershipclinical development
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Lifeward Regains Nasdaq Compliance After Stock Price Recovery

Lifeward Ltd. ($LFWD) has regained compliance with Nasdaq's $1.00 minimum bid price requirement, ending delisting risk for the medical technology company.
LFWDmedical technologyminimum bid price